FILING ANALYSIS · WEDNESDAY, JULY 1

Relief Therapeutics Holding Sa 0QKQ — RNS

positive

Relief Therapeutics' partner MindMaze Therapeutics has enrolled first patients in the SwissNeuroRehab study, a key step in advancing at-home neurorehabilitation reimbursement in Europe, which is a positive development for the company's growth prospects

The filing

Relief Therapeutics Holding Sa — Mindmaze Therapeutics Enrolls First Patients

Read the RNS announcement →

How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.

Get filings like this every market day

The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.

Subscribe free →